Go Pro

Insider Selling: Kinaxis (TSE:KXS) Director Sells 15,968 Shares

Kinaxis logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Director Gillian (Jill) Denham sold 15,968 Kinaxis shares at an average price of C$171.36, generating approximately C$2.74 million. Her remaining stake fell 46.02% to 18,732 shares.
  • Kinaxis shares recently traded at C$169.22, while the company reported quarterly EPS of C$1.08 and revenue of C$230.64 million. The stock has a market capitalization of C$4.60 billion and a P/E ratio of 55.30.
  • Analysts remain broadly optimistic, with seven Buy ratings and a consensus target price of C$203.12, implying upside from the reported trading price.
  • Five stocks we like better than Kinaxis.

Kinaxis Inc. (TSE:KXS - Get Free Report) Director Gillian (Jill) Denham sold 15,968 shares of the company's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of C$171.36, for a total transaction of C$2,736,276.48. Following the transaction, the director owned 18,732 shares in the company, valued at C$3,209,915.52. The trade was a 46.02% decrease in their position.

Kinaxis Stock Performance

Shares of TSE:KXS traded down C$1.52 on Wednesday, hitting C$169.22. 65,898 shares of the company were exchanged, compared to its average volume of 122,506. Kinaxis Inc. has a 1-year low of C$117.22 and a 1-year high of C$201.00. The stock's 50 day moving average price is C$158.22 and its 200 day moving average price is C$145.34. The company has a current ratio of 1.88, a quick ratio of 2.29 and a debt-to-equity ratio of 11.14. The firm has a market capitalization of C$4.60 billion, a P/E ratio of 55.30, a price-to-earnings-growth ratio of 3.60 and a beta of 0.76.

Kinaxis (TSE:KXS - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share (EPS) for the quarter. The firm had revenue of C$230.64 million for the quarter. Kinaxis had a return on equity of 20.88% and a net margin of 14.40%. Sell-side analysts predict that Kinaxis Inc. will post 4.2526231 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on KXS. Canadian Imperial Bank of Commerce lifted their target price on Kinaxis from C$173.00 to C$205.00 in a report on Friday, June 5th. National Bank Financial lifted their price objective on shares of Kinaxis from C$200.00 to C$210.00 and gave the company an "outperform" rating in a research note on Friday, August 7th. Stifel Nicolaus dropped their price objective on shares of Kinaxis from C$245.00 to C$200.00 and set a "buy" rating on the stock in a report on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on shares of Kinaxis from C$200.00 to C$210.00 and gave the stock an "outperform" rating in a research note on Friday, May 8th. Finally, BMO Capital Markets raised their target price on shares of Kinaxis from C$195.00 to C$200.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. Seven analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of C$203.12.

Read Our Latest Research Report on Kinaxis

Kinaxis Company Profile

(Get Free Report)

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain - from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption.

Recommended Stories

Insider Buying and Selling by Quarter for Kinaxis (TSE:KXS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines